HK1087328A1 - Therapeutic composition for autoimmune conditions - Google Patents

Therapeutic composition for autoimmune conditions

Info

Publication number
HK1087328A1
HK1087328A1 HK06107557.4A HK06107557A HK1087328A1 HK 1087328 A1 HK1087328 A1 HK 1087328A1 HK 06107557 A HK06107557 A HK 06107557A HK 1087328 A1 HK1087328 A1 HK 1087328A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic composition
autoimmune conditions
composition
given
autoimmune
Prior art date
Application number
HK06107557.4A
Other languages
English (en)
Inventor
Simon Mcewen
Original Assignee
Epidyme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epidyme Ltd filed Critical Epidyme Ltd
Publication of HK1087328A1 publication Critical patent/HK1087328A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06107557.4A 2003-04-07 2006-07-04 Therapeutic composition for autoimmune conditions HK1087328A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307989.4A GB0307989D0 (en) 2003-04-07 2003-04-07 Therapeutic composition
PCT/GB2004/001562 WO2004089405A1 (en) 2003-04-07 2004-04-07 Therapeutic composition for autoimmune conditions

Publications (1)

Publication Number Publication Date
HK1087328A1 true HK1087328A1 (en) 2006-10-13

Family

ID=9956332

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06107557.4A HK1087328A1 (en) 2003-04-07 2006-07-04 Therapeutic composition for autoimmune conditions

Country Status (11)

Country Link
US (2) US7901676B2 (xx)
EP (1) EP1610814B8 (xx)
JP (1) JP2006522086A (xx)
CN (1) CN1802172A (xx)
AT (1) ATE458495T1 (xx)
CA (1) CA2521602A1 (xx)
DE (1) DE602004025683D1 (xx)
GB (2) GB0307989D0 (xx)
HK (1) HK1087328A1 (xx)
MX (1) MXPA05010790A (xx)
WO (1) WO2004089405A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
CA2714399C (en) * 2007-12-12 2018-07-24 Dacy Tech Pty Ltd Compositions comprising extracts of biota orientalis and use thereof for treating cartilage degradation
US10376550B2 (en) 2007-12-12 2019-08-13 Dacy Tech Pty Ltd. Nutraceutical composition and methods of use
AU2008336268B2 (en) * 2007-12-12 2014-06-12 Dacy Tech Pty Ltd Nutraceutical composition and methods of use
ITMI20080357A1 (it) * 2008-03-04 2009-09-05 Sarm Allergeni Srl Proteina da haliotis midae e suo uso come agente immunoterapico
SG10201601905RA (en) * 2016-03-11 2017-10-30 Kah Meng Lim Extract And Method of Extraction

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2620649C3 (de) * 1976-05-11 1980-11-06 Behringwerke Ag, 3550 Marburg Immunologisches Adjuvans
US5268463A (en) * 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
GB8713906D0 (en) 1987-06-15 1987-07-22 Mcewen L M Beta-glucuronidase containing compositions
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
DE4125400C2 (de) * 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
DE19828450A1 (de) * 1998-06-26 1999-12-30 Hassan Jomaa Bisphosphonsäuren und deren Derivate enthaltende Arzneimittel zur Prophylaxe und zur Behandlung von Autoimmunkrankheiten sowie von Allergien
AR020717A1 (es) * 1998-10-07 2002-05-22 Syngenta Participations Ag Proteinas terapeuticamente activas en plantas.
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
WO2001070663A2 (en) * 2000-03-17 2001-09-27 Corixa Corporation Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
EP1228767A1 (en) 2001-01-31 2002-08-07 S.A.R.M. S.r.l. Use of beta-Glucuronidase for the treatment of immune or allergic diseases
CN1516595A (zh) * 2001-03-19 2004-07-28 Iomai公司 用于经皮免疫的贴剂
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
CA2469078A1 (en) * 2001-12-05 2003-06-12 Circassia Limited Immunotherapeutic methods and systems
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
US9549959B2 (en) * 2006-09-15 2017-01-24 I Did It, Inc. Animal chew toy containing solid food

Also Published As

Publication number Publication date
US20110135624A1 (en) 2011-06-09
CA2521602A1 (en) 2004-10-21
WO2004089405A1 (en) 2004-10-21
US20040228850A1 (en) 2004-11-18
JP2006522086A (ja) 2006-09-28
CN1802172A (zh) 2006-07-12
ATE458495T1 (de) 2010-03-15
US7901676B2 (en) 2011-03-08
MXPA05010790A (es) 2006-07-10
GB0307989D0 (en) 2003-05-14
EP1610814B1 (en) 2010-02-24
GB0407828D0 (en) 2004-05-12
GB2400556A (en) 2004-10-20
GB2400556B (en) 2005-10-19
EP1610814A1 (en) 2006-01-04
EP1610814B8 (en) 2010-06-02
DE602004025683D1 (de) 2010-04-08

Similar Documents

Publication Publication Date Title
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
WO2005049000A3 (en) Treatment of phenylketonurias with bh4
GB0001309D0 (en) Valve arrangement
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
TW200503751A (en) Methods for treating sinus headache
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
MXPA05010819A (es) Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
WO2006068729A3 (en) Methods and compositions for enhancing iron absorption
MXPA04005790A (es) Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona.
MY140581A (en) Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
HK1087328A1 (en) Therapeutic composition for autoimmune conditions
GB2396108B (en) Treatment of pain
MXPA02009904A (es) Derivados de apomorfina y metodos para su uso.
TW200518781A (en) Compositions for achieving benefits in skin using key cellular metabolic intermediates
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
EP1546182A4 (en) COMPOSITIONS AND METHOD FOR DIAGNOSING AND TREATING TUMORS
WO2004004653A3 (en) Methods for treating psychosis associated with interferon-alpha therapy
AU2001246600A1 (en) Use of comt inhibitors as analgesics
HUP0302748A2 (hu) Nagy szárítóképességgel rendelkező növényi olajat tartalmazó gombaölő készítmény
GB0323699D0 (en) Use of photosensitisation
MXPA04007491A (es) Tratamiento profilactico y terapeutico de infecciones y otras enfermedades con compuestos inmunoefectores.
SI1450782T1 (sl) Uporaba kombinirane zmesi, ki vsebuje propionil L-karnitin in dodatna zdravila za zdravljenje erektivne disfunkcije
PL1599211T3 (pl) Zastosowanie izorhamnetyny do leczenia nastrojów i chorób depresyjnych
AUPP379698A0 (en) Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
WO2003070167A3 (en) Therapeutic and prophylactic treatment of aging and disorders of aging in humans

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170407